Windtree Therapeutics, a Nasdaq-listed company, has announced plans to buy $60 million BNB as part of its push for a cryptocurrency treasury strategy. The company announced on July 16 that it had entered into a securities purchase agreement for $60…
Related Posts
25% of Bitcoin at Risk: Developers Push for Quantum-Resistant Upgrade
Developers are warning that a growing quantum computing threat could compromise 25% of Bitcoin’s supply due to exposed…
XRP whale activity ahead of Christmas attracts attention; BZ Mining gains focus, investors earn 1780 XRP a day
Unusual whale movements on the XRP network ahead of Christmas have heightened volatility and pushed investors to reconsider…
Kelexo celebrates Easter with stage 2 presale
As the defi sector gears up for a resurgence, Kelexo launches Stage 2 of its presale amid Easter…